Home
CADL
CADL News

Latest Candel Therapeutics Inc. (CADL) News on July 27, 2024

Candel Therapeutics to Participate in the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference

GlobeNewswire

a month ago

Candel Therapeutics to Participate in the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference

Candel Therapeutics' (NASDAQ:CADL) enLIGHTEN Discovery Platform Aims To Tackle Complexities Of Tumor Microenvironments

ACCESSWIRE

a month ago

Candel Therapeutics' (NASDAQ:CADL) enLIGHTEN Discovery Platform Aims To Tackle Complexities Of Tumor Microenvironments

Candel Therapeutics to Join Russell 3000® Index

GlobeNewswire

2 months ago

Candel Therapeutics to Join Russell 3000® Index

Lotto 6/49 - $64 million up for grabs in the next draw!

CNW Group

2 months ago

Lotto 6/49 - $64 million up for grabs in the next draw!

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Simply Wall St.

2 months ago

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Seoul says it will resume loudspeaker propaganda against North

AFP

2 months ago

Seoul says it will resume loudspeaker propaganda against North

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

Simply Wall St.

2 months ago

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Simply Wall St.

2 months ago

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Barrons.com

2 months ago

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

Simply Wall St.

2 months ago

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

Simply Wall St.

2 months ago

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

Candel Therapeutics (NASDAQ: CADL) Reports Positive Data From Phase 2 Trial Of CAN-2409 In Borderline Resectable Pancreatic Cancer

ACCESSWIRE

2 months ago

Candel Therapeutics (NASDAQ: CADL) Reports Positive Data From Phase 2 Trial Of CAN-2409 In Borderline Resectable Pancreatic Cancer

MT Newswires

2 months ago

FDA Grants Candel Therapeutics' CAN-3110 Orphan Drug Designation to Treat Recurrent High-Grade Glioma

FDA Grants Orphan Drug Designation for CAN-3110 for the Treatment of Recurrent High-Grade Glioma

GlobeNewswire

2 months ago

FDA Grants Orphan Drug Designation for CAN-3110 for the Treatment of Recurrent High-Grade Glioma

Candel (CADL) Stock Skyrockets 431% Year to Date: Here's Why

Zacks

2 months ago

Candel (CADL) Stock Skyrockets 431% Year to Date: Here's Why

Candel (CADL) Reports Upbeat Data From Lung Cancer Study

Zacks

2 months ago

Candel (CADL) Reports Upbeat Data From Lung Cancer Study

Candel Therapeutics Reports Prolonged Overall Survival in Phase 2 Clinical Trial of CAN-2409 for Advanced Non-Small Cell Lung Cancer (NSCLC) in Patients Non-Responsive to Immune Checkpoint Inhibitor (ICI) Treatment at 2024 ASCO Annual Meeting

GlobeNewswire

2 months ago

Candel Therapeutics Reports Prolonged Overall Survival in Phase 2 Clinical Trial of CAN-2409 for Advanced Non-Small Cell Lung Cancer (NSCLC) in Patients Non-Responsive to Immune Checkpoint Inhibitor (ICI) Treatment at 2024 ASCO Annual Meeting

Candel Therapeutics to Present at the Jefferies Global Healthcare Conference

GlobeNewswire

2 months ago

Candel Therapeutics to Present at the Jefferies Global Healthcare Conference

Candel Therapeutics to Host Non-Small Cell Lung Cancer (NSCLC) R&D Breakfast Panel During 2024 ASCO Annual Meeting

GlobeNewswire

2 months ago

Candel Therapeutics to Host Non-Small Cell Lung Cancer (NSCLC) R&D Breakfast Panel During 2024 ASCO Annual Meeting

Candel Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights

GlobeNewswire

2 months ago

Candel Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights

Candel Therapeutics Announces Upcoming Presentations at the 2024 ASCO Annual Meeting

GlobeNewswire

3 months ago

Candel Therapeutics Announces Upcoming Presentations at the 2024 ASCO Annual Meeting

Candel (CADL) Up as Pancreatic Cancer Drug Gets Orphan Drug Tag

Zacks

3 months ago

Candel (CADL) Up as Pancreatic Cancer Drug Gets Orphan Drug Tag

Candel Therapeutics Receives FDA Orphan Drug Designation for CAN-2409 for the Treatment of Pancreatic Cancer

GlobeNewswire

3 months ago

Candel Therapeutics Receives FDA Orphan Drug Designation for CAN-2409 for the Treatment of Pancreatic Cancer

Candel Therapeutics Presents Preclinical Data at AACR on Immunotherapy Candidate for Induction of Tertiary Lymphoid Structures in Solid Tumors

GlobeNewswire

4 months ago

Candel Therapeutics Presents Preclinical Data at AACR on Immunotherapy Candidate for Induction of Tertiary Lymphoid Structures in Solid Tumors

Retail investors invested in Candel Therapeutics, Inc. (NASDAQ:CADL) up 320% last week, insiders too were rewarded

Simply Wall St.

4 months ago

Retail investors invested in Candel Therapeutics, Inc. (NASDAQ:CADL) up 320% last week, insiders too were rewarded

Candel (CADL) Up on Upbeat Data From Pancreatic Cancer Study

Zacks

4 months ago

Candel (CADL) Up on Upbeat Data From Pancreatic Cancer Study

After Brain Cancer Data, Candel Therapeutics' Shares Good News From Pancreatic Cancer Study

Benzinga

4 months ago

After Brain Cancer Data, Candel Therapeutics' Shares Good News From Pancreatic Cancer Study

Candel Therapeutics Announces Positive Interim Data from Randomized Phase 2 Clinical Trial of CAN-2409 in Non-Metastatic Pancreatic Cancer

GlobeNewswire

4 months ago

Candel Therapeutics Announces Positive Interim Data from Randomized Phase 2 Clinical Trial of CAN-2409 in Non-Metastatic Pancreatic Cancer

Candel Therapeutics Announces Oral Presentation During the 5th Glioblastoma Drug Development Summit with Update on Phase 1b Clinical Trial of CAN-3110 in Recurrent High-Grade Glioma

GlobeNewswire

4 months ago

Candel Therapeutics Announces Oral Presentation During the 5th Glioblastoma Drug Development Summit with Update on Phase 1b Clinical Trial of CAN-3110 in Recurrent High-Grade Glioma

Candel Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Highlights

GlobeNewswire

4 months ago

Candel Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Highlights

Candel Therapeutics Announces an Upcoming Presentation at the AACR Annual Meeting Unveiling New Cancer Immunotherapy Candidate

GlobeNewswire

5 months ago

Candel Therapeutics Announces an Upcoming Presentation at the AACR Annual Meeting Unveiling New Cancer Immunotherapy Candidate

CAN-3110 Receives FDA Fast Track Designation for Treatment of Recurrent High-Grade Glioma

GlobeNewswire

5 months ago

CAN-3110 Receives FDA Fast Track Designation for Treatment of Recurrent High-Grade Glioma

Candel Therapeutics Sets Path to Success: Recent Achievements Pave the Way for a Promising 2024 Propelled by Key Value Drivers and Catalysts

GlobeNewswire

6 months ago

Candel Therapeutics Sets Path to Success: Recent Achievements Pave the Way for a Promising 2024 Propelled by Key Value Drivers and Catalysts

Associated Press Finance

6 months ago

IF Bancorp: Fiscal Q2 Earnings Snapshot

Business Wire

6 months ago

IF Bancorp, Inc. Announces Results for Second Quarter of Fiscal Year 2024

Business Wire

6 months ago

Cyclo Therapeutics Announces Allowance of Patent Application for Treatment of Alzheimer’s Disease from the U.S. Patent and Trademark Office

CFSB BANCORP, INC. ANNOUNCES FISCAL SECOND QUARTER AND YEAR-TO-DATE 2024 FINANCIAL RESULTS

PR Newswire

6 months ago

CFSB BANCORP, INC. ANNOUNCES FISCAL SECOND QUARTER AND YEAR-TO-DATE 2024 FINANCIAL RESULTS

ChromaDex to Present at the Lytham Partners 2024 Investor Select Conference

Business Wire

6 months ago

ChromaDex to Present at the Lytham Partners 2024 Investor Select Conference

GuruFocus.com

6 months ago

FVCBankcorp Inc (FVCB) Reports Mixed Results Amidst Strategic Repositioning

FVCBankcorp (FVCB) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks

6 months ago

FVCBankcorp (FVCB) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

D-Wave Joins Forces with Deloitte Canada to Advance Quantum Adoption

Business Wire

6 months ago

D-Wave Joins Forces with Deloitte Canada to Advance Quantum Adoption

Adicet Bio, Inc. Announces Pricing of Public Offering

Business Wire

6 months ago

Adicet Bio, Inc. Announces Pricing of Public Offering

Diamond in the Rough: 7 Dirt-Cheap Penny Stocks With 10X Potential

InvestorPlace

6 months ago

Diamond in the Rough: 7 Dirt-Cheap Penny Stocks With 10X Potential

Here's Why Allakos Inc. (ALLK) is Poised for a Turnaround After Losing -61.36% in 4 Weeks

Zacks

6 months ago

Here's Why Allakos Inc. (ALLK) is Poised for a Turnaround After Losing -61.36% in 4 Weeks

VirTra Debuts Advanced Training Content and True-Fire™ Recoil Kits at SHOT Show

GlobeNewswire

6 months ago

VirTra Debuts Advanced Training Content and True-Fire™ Recoil Kits at SHOT Show

Vox Announces New Revolving Credit Facility of up to $25 Million with Bank of Montreal

ACCESSWIRE

6 months ago

Vox Announces New Revolving Credit Facility of up to $25 Million with Bank of Montreal

Down -72.39% in 4 Weeks, Here's Why You Should You Buy the Dip in AlloVir, Inc. (ALVR)

Zacks

6 months ago

Down -72.39% in 4 Weeks, Here's Why You Should You Buy the Dip in AlloVir, Inc. (ALVR)

Pegasus Digital Mobility Acquisition Corp. Announces the Extension of the Combination Period until April 30, 2024

Business Wire

7 months ago

Pegasus Digital Mobility Acquisition Corp. Announces the Extension of the Combination Period until April 30, 2024

Business Wire

7 months ago

Cyclo Therapeutics, Inc. Completes Merger with Applied Molecular Transport Inc.

Karuna downgraded, Arm target raised: Wall Street's top analyst calls

The Fly

7 months ago

Karuna downgraded, Arm target raised: Wall Street's top analyst calls

The past five years for Sonida Senior Living (NYSE:SNDA) investors has not been profitable

Simply Wall St.

7 months ago

The past five years for Sonida Senior Living (NYSE:SNDA) investors has not been profitable

Business Wire

7 months ago

Cyclo Therapeutics Announces Positive Outcome from Type C Meeting with the U.S. FDA Discussing Trappsol® Cyclo™ Clinical Program for the Treatment of Niemann-Pick Disease Type C1

TCW Strategic Income Fund Announces Quarterly Distribution

Business Wire

7 months ago

TCW Strategic Income Fund Announces Quarterly Distribution

NXG Cushing® Midstream Energy Fund (NYSE: SRV) Announces the Preliminary Results of its Rights Offering

PR Newswire

7 months ago

NXG Cushing® Midstream Energy Fund (NYSE: SRV) Announces the Preliminary Results of its Rights Offering

CorMedix Inc. Announces Appointment of Chief Legal Officer

GlobeNewswire

7 months ago

CorMedix Inc. Announces Appointment of Chief Legal Officer

Rafael Holdings Reports First Quarter Fiscal 2024 Financial Results

GlobeNewswire

7 months ago

Rafael Holdings Reports First Quarter Fiscal 2024 Financial Results

Candel (CADL) Rises on FDA's Fast Track Status for CAN-2409

Zacks

7 months ago

Candel (CADL) Rises on FDA's Fast Track Status for CAN-2409

12 Best Micro-Cap Dividend Stocks To Buy Now

Insider Monkey

7 months ago

12 Best Micro-Cap Dividend Stocks To Buy Now

Should Value Investors Buy PetIQ (PETQ) Stock?

Zacks

7 months ago

Should Value Investors Buy PetIQ (PETQ) Stock?

TFF Pharmaceuticals Appoints Thomas B. King to Board of Directors

GlobeNewswire

7 months ago

TFF Pharmaceuticals Appoints Thomas B. King to Board of Directors

Candel Therapeutics Receives FDA Fast Track Designation for CAN-2409 in Pancreatic Cancer

GlobeNewswire

7 months ago

Candel Therapeutics Receives FDA Fast Track Designation for CAN-2409 in Pancreatic Cancer

Are Options Traders Betting on a Big Move in Cambium Networks (CMBM) Stock?

Zacks

8 months ago

Are Options Traders Betting on a Big Move in Cambium Networks (CMBM) Stock?

3 Underperforming Bank Stocks You Better Not Be Buying

InvestorPlace

8 months ago

3 Underperforming Bank Stocks You Better Not Be Buying

Jasper Announces First Patient Dosed in Phase 1b/2a Clinical Study of Briquilimab in Chronic Spontaneous Urticaria

GlobeNewswire

8 months ago

Jasper Announces First Patient Dosed in Phase 1b/2a Clinical Study of Briquilimab in Chronic Spontaneous Urticaria

Candel Therapeutics Announces Restructuring to Prioritize Resources on Key Value Drivers for Expanded Development of CAN-3110, the enLIGHTEN™ Discovery Platform, and Key Clinical Readouts for CAN-2409

GlobeNewswire

8 months ago

Candel Therapeutics Announces Restructuring to Prioritize Resources on Key Value Drivers for Expanded Development of CAN-3110, the enLIGHTEN™ Discovery Platform, and Key Clinical Readouts for CAN-2409

Business Wire

8 months ago

Western Asset Mortgage Opportunity Fund Inc. Announces Financial Position as of September 30, 2023

GuruFocus.com

9 months ago

Candel Therapeutics Inc (CADL) Reports Q3 2023 Financial Results and Clinical Progress

Candel Therapeutics Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights

GlobeNewswire

9 months ago

Candel Therapeutics Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights

InfuSystem Holdings, Inc. (AMEX:INFU) Q3 2023 Earnings Call Transcript

Insider Monkey

9 months ago

InfuSystem Holdings, Inc. (AMEX:INFU) Q3 2023 Earnings Call Transcript

MiX Telematics Reports Second Quarter Fiscal Year 2024 U.S. GAAP Financial Results

Business Wire

9 months ago

MiX Telematics Reports Second Quarter Fiscal Year 2024 U.S. GAAP Financial Results

Marchex Launches Generative AI-powered Call Summary and Sentiment Suite Capabilities for Vertical Markets

Business Wire

9 months ago

Marchex Launches Generative AI-powered Call Summary and Sentiment Suite Capabilities for Vertical Markets

Will Marchex (NASDAQ:MCHX) Spend Its Cash Wisely?

Simply Wall St.

9 months ago

Will Marchex (NASDAQ:MCHX) Spend Its Cash Wisely?

InflaRx Announces First Patient Dosed in Phase III Trial with Vilobelimab in Pyoderma Gangrenosum

GlobeNewswire

9 months ago

InflaRx Announces First Patient Dosed in Phase III Trial with Vilobelimab in Pyoderma Gangrenosum

Share on Social Networks: